Always discuss your alcohol consumption with your doctor
Topiramates Interactions: Topiramate can interact with a wide range of medications
Blood work schedules should be more frequent during initial combination therapy
Patients who exercised while using weight loss medication kept off substantially more weight after stopping treatment compared to non-exercisers
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are prescription drugs that mimic or boost the effects of the glucagon-like peptide-1 (GLP-1), which is a hormone released in response to eating
Key distinctions in the evidence: Tesamorelin: licensed in the US, narrowly indicated, established in HIV-related lipodystrophy, with effects that reverse on stopping treatment Retatrutide: investigational, broader metabolic potential, not yet approved anywhere globally Patients and clinicians should interpret early-phase data for retatrutide with appropriate caution